Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox is a research paper published in Immunity (2021). On theSindex it has a DataRank of 0.917. It has been cited 451 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Base Score Contribution
0.917
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology βNational Institutes of Health
Grant: K08AI139375
Prostate Cancer Foundation
Grant: R35CA253175
National Institutes of Health
Grant: 5R35CA253175-03
Determinants of response to cancer immunotherapy
National Institutes of Health
Grant: 5K08AI139375-04
Identification of circulating and tissue-specific autoimmune responses in checkpoint inhibitor-induced immune-related adverse events
AbbVie
Genentech
NCI
Bavarian Nordic
Parker Institute for Cancer Immunotherapy
Merck KGaA
Merck
Amgen
FWCI
23.47
Citation Percentile
1.0%
Influential Citations
3
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study
Additional file 1 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study
Additional file 1 of Effect of preoperative immunonutrition on postoperative short-term clinical outcomes in patients with gastric cancer cachexia: a prospective randomized controlled trial
Additional file 1 of Effect of preoperative immunonutrition on postoperative short-term clinical outcomes in patients with gastric cancer cachexia: a prospective randomized controlled trial
Additional file 1 of A pH-triggered N-oxide polyzwitterionic nano-drug loaded system for the anti-tumor immunity activation research
Additional file 1 of A pH-triggered N-oxide polyzwitterionic nano-drug loaded system for the anti-tumor immunity activation research
Additional file 1 of Molecular subtyping and the construction of a predictive model of colorectal cancer based on ion channel genes
Additional file 1 of Molecular subtyping and the construction of a predictive model of colorectal cancer based on ion channel genes
Additional file 2 of Molecular subtyping and the construction of a predictive model of colorectal cancer based on ion channel genes
Additional file 2 of Molecular subtyping and the construction of a predictive model of colorectal cancer based on ion channel genes
Additional file 1 of Immune cell infiltration and inflammatory landscape in primary brain tumours
Additional file 1 of Immune cell infiltration and inflammatory landscape in primary brain tumours
Additional file 5 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study
Additional file 7 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study
Additional file 8 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study
Additional file 5 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study
Additional file 6 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study
Additional file 6 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study
Additional file 7 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study
Additional file 8 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study